Skip to content

Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures

Identifying Risks of Outbreaks in Work Settings and the Implications for Control Measures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05197673
Enrollment
310
Registered
2022-01-19
Start date
2022-03-15
Completion date
2023-05-30
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intention to Get SARS-CoV-2 Antibody Test, Intention to Get SARS-CoV-2 Vaccination

Keywords

workplace hazards, exposure prevention, vaccination, SARS-CoV-2, control measures, willingness, attitude, antibody testing

Brief summary

Objectives: To identify core and cross-time workplace hazards and worker's exposure prevention profile towards outbreaks in three non-healthcare work settings; to evaluate effectiveness of a theory-based educational programme on improving attitude to vaccination and virus testing in workplace; to longitudinally compare attitude of willingness to vaccination, testing of SARS-CoV-2 and changes of risk profile toward outbreaks among workers. Design: A 5-year study comprising a randomized controlled trial (RCT) and 3 parallel longitudinal studies with baseline and follow-up repeated measurements. Setting: Non-office, mobile and office work settings. Participants: Part I is a RCT, 294 workers will be randomised to an intervention group (a theory-based education programme) and a control group with measurements repeated at 3rd, 6th and 9th month. Part II is a longitudinal quantitative study (i.e., prospective cohort study) involving 1,495 workers recruited at the baseline and followed up for 2 years. Part III is a longitudinal qualitative study involving 26 management and frontline workers. Part IV is a longitudinal workplace hygiene study involving 6 workplaces enrolled at the baseline and followed up to conduct ventilation investigation. Intervention: Theory-based education intervention to build positive attitude of control measures towards SARS-CoV-2 outbreak. Main outcome measure: Workplace hygiene data (airflow, air volume, etc.); willingness to vaccination and virus tests; actual uptake of SARS-CoV-2 antibody testing. Data analyses: Multivariate regression logistic model and thematically analysed will be performed for quantitative and qualitative analysis. Intention-to-treat analysis will be employed for RCT. Expected results: Large dataset of longitudinal measurement of willingness to vaccination/testing and actual uptake will be documented to inform policy. Educational intervention will be developed to mitigate risks of outbreaks in workplace.

Interventions

BEHAVIORALTheory of planned behaviours (TPB) based intervention

Intervention group will receive TPB-based education program to improve workers' attitude toward SARS-CoV-2 and raise their intention to vaccination and virus testing. The intervention will be implemented at the baseline with measurements repeated at the 3rd month, 6th month and 9th month. The standardized mode of intervention includes face-to-face/online seminar (depends on the COVID-19 situation), message via mobile phone, promotion pamphlet, etc.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Intervention group will receive theory-based educational intervention using the Theory of Planned Behaviours (TPB) PLUS general health information; Control group will receive only general health information.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* currently being employed in Hong Kong

Exclusion criteria

* who have history of physician-diagnosed cancer and sever chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
Change of intention to get vaccination of SARS-CoV-23rd, 6th and 9th monthA questionnaire will be used to evaluate the intention to get vaccination quantitively. This assessment will be repeated in the 3rd, 6th and 9th month. Change will be assessed among these time points.

Secondary

MeasureTime frameDescription
Change of intention to uptake SARS-CoV-2 antibody test3rd, 6th and 9th monthA questionnaire will be used to evaluate the intention to get rapid antibody test quantitively. This assessment will be repeated in the 3rd, 6th and 9th month. Change will be assessed among these time points.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026